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Abstract 
 
SLC26A4 encodes pendrin, a transporter exchanging anions such as chloride, bicarbonate, and 
iodide. Loss of function mutations of SLC26A4 cause Pendred syndrome characterized by 
hearing loss and enlarged vestibular aqueducts as well as variable hypothyroidism and goiter. In 
the kidney, pendrin is expressed in the distal nephron and accomplishes HCO3- secretion and Cl- 
reabsorption. Renal pendrin expression is regulated by acid-base balance. The liver contributes to 
acid-base regulation by producing or consuming glutamine, which is utilized by the kidney for 
generation and excretion of NH4+, paralleled by HCO3- formation. Little is known about the 
regulation of pendrin in liver. The present study thus examined the expression of Slc26a4 in liver 
and kidney of mice drinking tap water without or with NaHCO3 (150 mM), NH4Cl (280 mM) or 
acetazolamide (3.6 mM) for seven days. As compared to Gapdh transcript levels, Slc26a4 
transcript levels were moderately lower in liver than in renal tissue. Slc26a4 transcript levels 
were not significantly affected by NaHCO3 in liver, but significantly increased by NaHCO3 in 
kidney. Pendrin protein expression was significantly enhanced in kidney and reduced in liver by 
NaHCO3. Slc26a4 transcript levels were significantly increased by NH4Cl and by acetazolamide 
in liver, and significantly decreased by NH4Cl and by acetazolamide in kidney. NH4Cl and 
acetazolamide reduced pendrin protein expression significantly in kidney, but did not 
significantly modify pendrin protein expression in liver. The observations point to expression of 
pendrin in the liver and to opposite effects of acidosis on pendrin transcription in liver and 
kidney.  
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Introduction 
 
SLC26A4 encodes pendrin, an anion exchanger transporting chloride, bicarbonate, 
iodide and a variety of further anions [Choi et al., 2011]. Loss of function defects of 
SLC26A4 [Dossena et al., 2009] result in autosomal-recessive Pendred syndrome (PDS), 
characterized by sensorineural hearing loss and enlarged vestibular aqueducts [Choi et al., 
2011; Lang et al., 2007; Maciaszczyk and Lewinski 2008] as well as an iodide organification 
defect with enhanced susceptibility to develop goiter and hypothyroidism [Bizhanova and 
Kopp 2009; Calebiro et al., 2010; Choi et al., 2011]. The development of goiter and 
hypothyroidism vary and partially but not fully depends on nutritional iodide intake 
[Bizhanova and Kopp 2010; Calebiro et al., 2010]. 
Slc26a4 expression is most abundant in the thyroid gland, the inner ear, and the kidney 
[Bizhanova and Kopp 2009; Bizhanova and Kopp 2010]. In the thyroid, slc26a4 participates 
in the transport of iodide [Bizhanova and Kopp 2009; Bizhanova and Kopp 2010]. Slc26a4 is 
further expressed in lung tissue and participates in the regulation of mucus production 
[Izuhara et al., 2009]. It has been suggested that IL-13 induced slc26a4 expression contributes 
to the pathophysiology of bronchial asthma [Izuhara et al., 2009]. 
In the kidney, slc26a4 is expressed in the apical membrane of type B and non-A, non-
B intercalated cells of distal convoluted tubule, connecting tubule and cortical collecting duct 
and thus accomplishes HCO3- secretion and Cl- reabsorption in the distal nephron [Carraro-
Lacroix and Malnic 2010; Sindic and Schlatter 2007; Wagner et al., 2009; Wall and Pech 
2010]. Slc26a4 expression and function is increased at enhanced aldosterone or angiotensin II 
levels and slc26a4 function contributes to the hypertensive effect of those hormones [Eladari 
et al., 2009; Wall and Pech 2010]. Slc26a4 modifies the expression of the epithelial Na+ 
channel ENaC, an effect attributed, at least in part, to its impact on luminal HCO3- 
concentration [Wall and Pech 2010].  
Slc26a4 activity and expression in the kidney is regulated by the acid-base status 
[Hafner et al., 2008; Wagner et al., 2002; Wagner et al., 2009]. Generation of HCO3- in type B 
intercalated cells is accomplished by a cellular carbonic anhydrase (CAII) and a H+-ATPase at 
the basolateral membrane [Carraro-Lacroix and Malnic 2010; Sun et al., 2008]. Carbonic 
anhydrase II deficiency decreases Slc26a4 expression in the kidney [Sun et al., 2008]. 
Regulation of systemic acid-base balance requires coordinated functions of the liver 
and the kidneys [Guder et al., 1987]. Acid-base regulation involves renal ammoniagenesis and 
hepatic urea production, which are tied together by interorgan glutamine flux. Glutamine 
could be either used in the liver for urea formation or in the kidney for generation and 
excretion of ammonia [Guder et al., 1987]. Renal ammonia excretion but not hepatic urea 
formation is paralleled by generation of HCO3-. Accordingly, metabolic acidosis is followed 
by a shift from the use of glutamine for hepatic urea formation to the use of glutamine for 
renal ammonium formation and excretion [Guder et al., 1987; Karim et al., 2002; Nissim 
1999]. 
Little is known about expression of Slc26a4 in the liver. The present study thus 
explored whether liver tissue expresses Slc26a4 and whether hepatic Slc26a4 expression is 
influenced by acid-base balance in a similar way as in the kidney. To this end, Slc26a4 
transcript and protein levels were quantified in liver and kidney from mice treated with 
bicarbonate to induce metabolic alkalosis [Huber et al., 1999], ammonium chloride to trigger 
metabolic acidosis [Nowik et al., 2010] and acetazolamide to inhibit carbonic anhydrase 
[Lonnerholm et al., 1986].  
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Materials and Methods 
 
Animals 
Experiments were performed in 8-10 week old female and male C57Bl/6J mice. All 
animal experiments were conducted according to German and Swiss laws for the welfare of 
animals and were approved by local authorities. The animals had free access to food (C1310, 
Altromin, Heidenau, Germany) and tap water. Where indicated NaHCO3 (150 mM), NH4Cl (280 
mM) or acetazolamide (3.6 mM) were added to the drinking water for 7 days. Drinking volumes 
and body weight were determined prior to and during the experimental period. 
 
Determination of blood pH and pCO2   
Blood samples were collected from the retrobulbar venous plexus to determine pH and 
pCO2. The pH was determined utilizing an electrode and pCO2 utilizing a blood gas analyzer 
(ABL80 FLEX CO-OX, Radiometer, Willich, Germany). Plasma HCO3- concentration was 
calculated from pCO2 and pH utilizing the Henderson Hasselbach equation [Harrison 1995]. 
 
RT-PCR analysis 
To determine Slc26a4 mRNA abundance in mouse liver and kidney RNA was 
extracted from both tissues using Trifast Reagent (Peqlab, Erlangen, Germany) according to 
the manufacturer’s instructions. Reverse transcription of 2 µg RNA was performed using 
oligo(dT)12-18 primers (Invitrogen, Karlsruhe, Germany) and SuperScript III Reverse 
Transcriptase (Invitrogen, Karlsruhe, Germany). cDNA samples were treated with RNase H 
(Invitrogen, Karlsruhe, Germany). Quantitative RT-PCR was performed with the iCycler 
iQTM Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA) and iTaqTM 
Sybr Green Supermix with ROX (Bio-Rad Laboratories, Hercules, CA) according to the 
manufacturer’s instructions. The following primers were used (5’→3’ orientation): Slc26a4 s: 
TTCGGTCTCTACTCTGCCTTT; Slc26a4 as: CCCACCATTAAACTGACCACG; Gapdh s: 
AGGTCGGTGTGAACGGATTTG; Gapdh as: TGTAGACCATGTAGTTGAGGTCA. The 
specificity of the PCR products was confirmed by analysis of the melting curves and in 
addition by agarose gel electrophoresis. All PCRs were performed in duplicate, and mRNA 
fold changes were calculated by the ΔΔCt method using Gapdh as internal reference.  
 
Membrane preparation and western blot analysis 
 For total membrane preparation kidney and liver samples were homogenized in an ice-
cold K-HEPES buffer (200 mM mannitol, 80 mM HEPES, 41 mM KOH, pH 7.5) containing 
a protease inhibitor mix (Complete Mini, Roche Diagnostics, Germany) at a final 
concentration of 1 tablet in a volume of 10 ml solution. Samples were centrifuged at 2000 rpm 
for 20 min at 4°C. Subsequently, the supernatant was transferred to a new tube and 
centrifuged at 41000 rpm for 1 h at 4°C. The resultant pellet was resuspended in K-HEPES 
buffer containing protease inhibitors. After measurement of the total protein concentration 
(Bio-Rad Dc Protein Assay; Bio-Rad, Hercules, CA, USA), 10 (kidney) or 50 (liver) µg of 
crude membrane proteins were solubilized in Laemmli sample buffer, and SDS-PAGE was 
performed on 8% polyacrylamide gels. For immunoblotting, proteins were transferred 
electrophoretically to polyvinylidene difluoride membranes (Immobilon-P; Millipore, 
Bedford, MA, USA). After blocking with 5% milk powder in Tris-buffered saline/0.1% 
Tween-20 for 60 min, the blots were incubated with the respective primary antibodies (rabbit 
anti-pendrin 1:5000 [Hafner et al., 2008] and mouse monoclonal anti-β-actin antibody (42 
kDa; Sigma, St. Louis, MO, USA) 1:5000, diluted in 1%milk/TBS-T) either for 2 h at room 
temperature or overnight at 4°C. After washing and subsequent blocking, the membranes 
were incubated for 1 h at room temperature with the secondary antibody: goat anti-rabbit or 
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anti-mouse IgG-conjugated with alkaline phosphatase 1:5000 (Promega, WI, USA). Antibody 
binding was detected with the CDP-Star Western chemiluminescence kit (Roche Diagnostics, 
Mannheim, Germany) using the DIANA III-chemiluminescence detection system (Raytest; 
Straubenhardt, Germany). All images were analyzed using appropriate software (Advanced 
Image Data Analyzer, Raytest, Straubenhardt, Germany) to calculate the protein of interest/β-
actin ratio. 
 
Statistical analysis  
As indicated, data are provided as means ± SEM; n represents the number of 
independent experiments. All data were tested for significance using Student’s unpaired two-
tailed t-test, or ANOVA, where applicable. Only results with *(p<0.05), **(p<0.01) or 
***(p<0.001) were considered statistically significant. 
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Results 
 
 In order to determine the abundance of mRNA encoding Slc26a4 in hepatic and renal 
tissue, semi-quantitative reverse transcription polymerase chain reaction (RT-qPCR) was 
employed. As illustrated in Fig.1A, Slc26a4 mRNA was detected in both, hepatic and renal 
tissue. mRNA expression was moderately lower in liver than in kidney. The Slc26a4 
transcript levels were normalized to the transcript levels of the house keeping gene Gapdh. 
Again, the Slc26a4/Gapdh transcript level ratio was moderately lower in liver (0.51 ± 0.04, n 
= 4) than in kidney (1.00 ± 0.04, n = 4). Immunoblotting with antibodies raised against 
pendrin detected bands in kidney and liver that were not found when the antibody was 
preincubated with the immunizing peptide (Fig. 1B). Of note, pendrin in liver displayed a 
slightly higher molecular weight than in liver. 
 Further experiments were performed to explore the influence of alkalosis and acidosis 
on Slc26a4 transcript levels in liver and kidney. To this end animals were drinking either 
plain tap water or either, 150 mM NaHCO3, 280 mM NH4Cl or 3.6 mM acetazolamide for 7 
days. The daily fluid intake approached 4.3 ± 0.1 ml (n = 4), 4.8 ± 0.1 µl (n = 4), 4.1 ± 0.1 µl 
(n = 4), and 2.1 ± 0.1 µl (n = 4), respectively, in water, NaHCO3, NH4Cl and acetazolamide 
drinking animals. The body weight change during the experimental period approached 0.6 ± 
0.2 g (n = 4), 0.6 ± 0.2 g (n = 4), 0.4 ± 0.1 g (n =4), and 6.4 ± 0.4 g (n = 4), in water, 
NaHCO3, NH4Cl and acetazolamide drinking animals. Plasma pH did not significantly change 
following drinking of NaHCO3, but significantly decreased following drinking of NH4Cl or 
acetazolamide (Table 1).  
 The switch from water to NaHCO3 did not significantly modify Slc26a4 mRNA 
expression in liver, but significantly increased Slc26a4 mRNA expression in kidney (Fig. 1C). 
NaHCO3 significantly increased pendrin protein abundance in kidney and significantly 
decreased pendrin protein expression in liver (Fig. 2, n = 5/group).  
 The switch from water to NH4Cl was followed by a profound increase of Slc26a4 
mRNA expression in liver, but to a similarly profound decrease of Slc26a4 mRNA expression 
in the kidney (Fig. 3). On the protein level, NH4Cl treatment did not significantly modify 
pendrin protein expression in liver but significantly reduced pendrin expression in kidney 
(Fig. 4)  
Treatment of the animals with acetazolamide was again followed by a profound 
increase of Slc26a4 mRNA expression in liver and to a similarly profound decrease of  
Slc26a4 mRNA expression in the kidney (Fig. 5) Acetazolamide strongly and significantly 
reduced pendrin protein levels in kidney but did not significantly modify pendrin protein 
expression in liver (Fig. 6). 
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Discussion 
 
 The present study demonstrates that Slc26a4 transcript and protein levels could be 
detected in hepatic tissue. The transcript level was moderately lower in liver than in kidney, 
but the data strongly suggest that substantial amounts of pendrin are expressed in hepatic 
tissue. Western blotting confirmed the expression of pendrin protein in the liver.   
The present observations further demonstrate sensitivity of hepatic and renal Slc26a4 
mRNA and protein expression to acidosis and alkalosis. Both, NH4Cl [Nowik et al., 2010] 
and acetazolamide [Lonnerholm et al., 1986] are known to cause acidosis, which in turn 
down-regulates renal Slc26a4 expression [Wagner et al., 2009]. Following acidosis, renal H+ 
secretion is up-regulated and renal bicarbonate secretion is down-regulated [Hafner et al., 
2008; Wagner et al., 2009]. Since pendrin is inserted into the apical cell membrane and 
accomplishes HCO3- secretion, its operation would be counterproductive for renal acid 
elimination during acidosis [Carraro-Lacroix and Malnic 2010; Sindic and Schlatter 2007; 
Wagner et al., 2009; Wall and Pech 2010]. Along those lines, renal Slc26a4 transcript levels 
are decreased in animals lacking Carbonic anhydrase II [Sun et al., 2008] and its protein 
abundance is reduced in rats treated with the carbonic anhydrase inhibitor acetazolamide 
[Welsh-Bacic et al., 2011]. 
The effect of acidosis on the Slc26a4 transcript levels in liver were opposite to what 
was observed in the kidney. Both, NH4Cl and acetazolamide significantly increased pendrin 
transcript levels in the liver. However, neither NH4Cl nor acetazolamide significantly 
modified pendrin protein expression. Thus, it remains uncertain, whether the enhanced 
pendrin transcript levels indeed translate into the respective alterations of protein expression.  
 In theory, Slc26a4 may serve a second function in the liver, i.e. cell volume regulation. 
Parallel activation of Na+/H+ exchangers and Cl-/HCO3- exchangers accomplish regulatory cell 
volume increase [Hoffmann et al., 2009; Lang et al., 1998], as they mediate cellular uptake of 
NaCl, which in turn osmotically drives water entry. The extrusion of H+ and HCO3- by the 
Na+/H+ exchanger and the Cl-/HCO3- exchanger, respectively, is osmotically not relevant, as they 
are replenished in the cell from CO2 via H2CO3 [Hoffmann et al., 2009; Lang et al., 1998]. Na+ 
accumulated by the Na+/H+-exchanger is pumped out by the Na+/K+-ATPase in exchange for K+. 
Thus, the transporters eventually accomplish cellular KCl-uptake [Hoffmann et al., 2009; Lang 
et al., 2007].  
 Cell volume is in turn a decisive regulator of hepatic metabolism. Cell shrinkage 
stimulates proteolysis and inhibits protein synthesis in the liver, and, conversely, cell swelling 
stimulates protein synthesis and inhibits proteolysis [Haussinger and Lang 1991; Stoll et al., 
1992; vom Dahl et al., 2001; vom Dahl and Haussinger 1995]. Similarly, cell swelling inhibits 
and cell shrinkage stimulates glycogenolysis [Lang et al., 1989]. As a result, following cell 
swelling, the intracellular amino acids and glucose are incorporated into and upon cell shrinkage 
they are released from the osmotically less active macromolecules [Lang et al., 1998]. Cell 
volume further influences glycolysis, flux through the pentose phosphate pathway, lipogenesis 
from glucose, gluconeogenesis, oxidation of glycine and alanine, degradation of glutamine, 
degradation of amino acids to NH4+ and urea, ketoisocaproate oxidation, acetyl CoA 
carboxylase, lipogenesis, carnitine palmitoyltransferase I activity, cytosolic ATP and 
phosphocreatine concentrations, respiration and RNA and DNA synthesis [Haussinger 2008; 
Haussinger and Lang 1991; Lang et al., 1998]. Whether or not pendrin indeed participates in cell 
volume regulatory transport, remains, however, to be tested. 
 In conclusion, Slc26a4 transcripts and protein were observed in liver tissue. The 
abundance of both was only moderately lower than in the kidney. The hepatic Slc26a4 
transcript levels were upregulated by NH4Cl and acetazolamide. On protein level, hepatic 
Slc26a4 decreased in response to NaHCO. Thus, pendrin transcription and/or protein 
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expression is presumably governed by acid-base balance. The present observations point to a 
novel role of pendrin, i.e. Cl-/HCO3- exchange in liver cells. 
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Table 1: Plasma pH, plasma CO2 partial pressure (pCO2, mmHg),  as well as plasma  Na+, 
K+, and Cl- concentration (mM) in water, NaHCO3 (150 mM), NH4Cl (280 mM) and 
acetazolamide (3.6 mM) drinking animals (arithmetic means ± SEM, n = 5)  
Drinking fluid pH pCO2  Na+  K+  Cl-  cHCO3- n 
water  7.39 ± 0.01 41.5 ± 0.8 143.2 ± 0.4 4.9 ± 0.2 111.4 ± 1.3 24.9 ± 0.7 5 
NaHCO3 7.38 ± 0.01 41.0 ± 2.0 143.2 ± 0.4 4.8 ± 0.1 111.2 ± 0.6 23.9 ± 1.5 5 
NH4Cl 7.29 ± 0.03** 41.2 ± 1.2 147.6 ± 1.2** 4.7 ± 0.1 119.6 ± 0.7*** 19.4 ± 1.0** 5 
Acetazolamide  7.22 ± 0.01*** 50.6 ± 1.3*** 148.6 ± 0.7*** 4.8 ± 0.1 122.0 ± 0.9*** 19.9 ± 0.4** 5 
** (p<0.01), *** (p<0.001) indicate statistically significant differences to water drinking 
animals. 
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Figures 
 
 
Fig. 1: Slc26a4 mRNA abundance in liver and kidney of water and NaHCO3 drinking 
animals  
A. Representative original bands of mRNA encoding Slc26a4 (upper bands) in kidney (left 
bands) and liver (right bands). The housekeeping gene Gapdh (lower bands) served as a 
calibrator and control.   
B. Detection of pendrin protein by immunoblotting of mouse kidney and liver. The signal was 
abolished by preincubation of the immune-serum with the immunizing peptide. The house-
keeping protein β-actin served as positive control. 
C. Arithmetic means ± SEM of Slc26a4 mRNA abundance in liver (left) (n = 6-8) and kidney 
(right) (n = 8) of animals drinking water (white bars) or drinking 150 mM NaHCO3 (black 
bars) for seven days. * (p<0.05) indicates statistically significant difference to water drinking 
animals. 
 
Fig. 2: Slc26a4 protein abundance in liver and kidney from mice exposed to NaHCO3 in 
drinking water 
Representative original blot for pendrin in liver (left panel) and kidney (right panel) from 
animals drinking NaHCO3 in drinking water for 7 days. All blots were stripped and reprobed 
for β-actin. Bar graphs summarize data from blots. Pendrin abundance was normalized 
against β-actin on the same blot. Arithmetic means ± SEM are shown for n = 5 animals/group. 
** (p<0.01) and *** (p<0.001) indicate statistically significant differences to water drinking 
animals. 
 
Fig. 3: Slc26a4 mRNA abundance in liver and kidney of water and NH4Cl drinking 
animals  
Arithmetic means ± SEM of Slc26a4 mRNA abundance in liver (left) (n = 7) and kidney 
(right) (n = 6-7) of animals drinking water (white bars) or drinking 280 mM NH4Cl (black 
bars) for seven days. * (p<0.05) indicates statistically significant difference to water drinking 
animals. 
 
Fig. 4: Slc26a4 protein abundance in liver and kidney from mice receiving NH4Cl in 
drinking water 
Representative original blot for pendrin in liver (left panel) and kidney (right panel) from 
animals drinking NH4Cl in drinking water for 7 days. All blots were stripped and reprobed for 
β-actin. Bar graphs summarize data from blots. Pendrin abundance was normalized against β-
actin on the same blot. Arithmetic means ± SEM are shown for n = 5 animals/group. *** 
(p<0.001) indicate statistically significant differences to water drinking animals. 
 
Fig. 5: Slc26a4 mRNA abundance in liver and kidney of animals following drinking of 
water without or with acetazolamide  
Arithmetic means ± SEM of Slc26a4 mRNA abundance in liver (left) (n = 7-8) and kidney 
(right) (n = 7-8) of animals drinking water (white bars) or drinking 3,6 mM acetazolamide 
(black bars) for seven days. * (p<0.05) indicates statistically significant difference to water 
drinking animals. 
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Fig. 6: Slc26a4 protein abundance in liver and kidney from mice treated with 
acetazolamide 
Representative original blot for pendrin in liver (left panel) and kidney (right panel) from 
animals drinking acetazolamide in drinking water for 7 days. All blots were stripped and 
reprobed for β-actin. Bar graphs summarize data from blots. Pendrin abundance was 
normalized against β-actin on the same blot. Arithmetic means ± SEM are shown for n = 5 
animals/group. *** (p<0.001) indicate statistically significant differences to water drinking 
animals. 
 
Fig. 7: Cartoon illustrating the cooperation of liver and kidney in acidosis (left) and 
alkalosis (right). 
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